Live attenuated and non-live vaccines can be administered in combination
the verdict
SUPPORTED
the evidence backs this
confidence 82/100
Multiple clinical trials and studies demonstrate that live attenuated and non-live (inactivated or subunit) vaccines can be safely administered in combination without interfering with their respective immunogenic responses.
Evidence for · 6
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen
2014 · cited by 12
Paper [0] demonstrates the feasibility and enhanced immunological potential of combining live attenuated BCG with a plasmid DNA vaccine.
See more details
More for · 5
Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial
2021 · cited by 10
Paper [1] shows that co-administering an inactivated EV71 vaccine with live-attenuated MMR and Japanese encephalitis vaccines is safe and non-inferior in immunogenicity.
Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
2023 · cited by 7
Paper [2] confirms that live attenuated varicella vaccine can be safely and effectively co-administered with inactive hepatitis A vaccine.
Safety and Immunogenicity of Vaccines in Children with Kaposiform Hemangioendothelioma Receiving Sirolimus: A Prospective Study
2025 · cited by 3
Paper [4] finds that administering both inactivated and live-attenuated vaccines is safe and immunogenic in pediatric patients.
Immunogenicity and safety of co-administration of sabin-strain-based inactivated poliovirus vaccine, diphtheria-tetanus-acellular pertussis vaccine, and live attenuated hepatitis A vaccine in 18-month-old children: A multicenter randomized controlled non-inferiority trial in China.
2025 · cited by 2
Paper [5] reports that the co-administration of inactivated poliovirus vaccine, DTaP, and live attenuated hepatitis A vaccine is immunologically non-inferior with an acceptable safety profile.
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles–Mumps–Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial
2025 · cited by 2
Paper [6] establishes that a Sabin strain inactivated poliovirus booster can be concomitantly administered with MMRV or inactivated hepatitis A vaccine without compromising immunogenicity.